Utilizing chemical genomics to identify cytochrome b as a novel drug target for chagas disease

HIGHLIGHTS

• who: Shilpi Khare et al. from the Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America, Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, San have published the paper: Utilizing Chemical Genomics to Identify Cytochrome b As a Novel Drug Target for Chagas Disease, in the Journal: (JOURNAL) of July/17,/2015
• what: The authors report GNF7686 small molecule inhibitor of Trypanosoma cruzi the causative agent of Chagas disease and identification of cytochrome b as its target. The authors report identification of potent inhibitor of T . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.